Literature DB >> 31796914

Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells.

Torri L Jordan1,2, Khansaa Maar2, Keely R Redhage2, Pinaki Misra2, Luis M Blancas-Mejia2, Christopher J Dick2, Jonathan S Wall3, Angela Williams3, Allan B Dietz4, Andre J van Wijnen2,5,6, Yi Lin7,8, Marina Ramirez-Alvarado9,10.   

Abstract

Light chain (AL) amyloidosis is a progressive, degenerative disease characterized by the misfolding and amyloid deposition of immunoglobulin light chain (LC). The amyloid deposits lead to organ failure and death. Our laboratory is specifically interested in cardiac involvement of AL amyloidosis. We have previously shown that the fibrillar aggregates of LC proteins can be cytotoxic and arrest the growth of human RFP-AC16 cardiomyocytes in vitro. We showed that adipose-derived mesenchymal stromal cells (AMSC) can rescue the cardiomyocytes from the fibril-induced growth arrest through contact-dependent mechanisms. In this study, we examined the transcriptome changes of human cardiomyocytes and AMSC in the presence of AL amyloid fibrils. The presence of fibrils causes a 'priming' immune response in AMSC associated with interferon associated genes. Exposure to AL fibrils induced changes in the pathways associated with immune response and extracellular matrix components in cardiomyocytes. We also observed upregulation of innate immune-associated transcripts (chemokines, cytokines, and complement), suggesting that amyloid fibrils initiate an innate immune response on these cells, possibly due to phenotypic transformation. This study corroborates and expands our previous studies and identifies potential new immunologic mechanisms of action for fibril toxicity on human cardiomyocytes and AMSC rescue effect on cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31796914      PMCID: PMC7196017          DOI: 10.1038/s41375-019-0640-4

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  39 in total

Review 1.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

2.  CyBorD: stellar response rates in AL amyloidosis.

Authors:  Giampaolo Merlini
Journal:  Blood       Date:  2012-05-10       Impact factor: 22.113

Review 3.  Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.

Authors:  Morie A Gertz
Journal:  Am J Hematol       Date:  2016-09       Impact factor: 10.047

Review 4.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

5.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

6.  Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.

Authors:  Joseph R Mikhael; Steven R Schuster; Victor H Jimenez-Zepeda; Nancy Bello; Jacy Spong; Craig B Reeder; A Keith Stewart; P Leif Bergsagel; Rafael Fonseca
Journal:  Blood       Date:  2012-02-13       Impact factor: 22.113

7.  Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

Authors:  Daniel A Brenner; Mohit Jain; David R Pimentel; Bo Wang; Lawreen H Connors; Martha Skinner; Carl S Apstein; Ronglih Liao
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367

8.  Cellular response of cardiac fibroblasts to amyloidogenic light chains.

Authors:  Vickery Trinkaus-Randall; Mary T Walsh; Shawn Steeves; Grace Monis; Lawreen H Connors; Martha Skinner
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

9.  Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes.

Authors:  Rebecca T Levinson; Oludare O Olatoye; Edward G Randles; Kyle G Howell; Ara Celi DiCostanzo; Marina Ramirez-Alvarado
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture.

Authors:  L A Sikkink; M Ramirez-Alvarado
Journal:  Cell Death Dis       Date:  2010-11-11       Impact factor: 8.469

View more
  3 in total

1.  A Proteomic Atlas of Cardiac Amyloid Plaques.

Authors:  Taxiarchis V Kourelis; Surendra S Dasari; Angela Dispenzieri; Joseph J Maleszewski; Margaret M Redfield; Ahmed U Fayyaz; Martha Grogan; Marina Ramirez-Alvarado; Omar F Abou Ezzeddine; Ellen D McPhail
Journal:  JACC CardioOncol       Date:  2020-11-17

Review 2.  Molecular Mechanisms of Cardiac Amyloidosis.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Hiroshi Ito
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

3.  Global Left Ventricular Myocardial Work Efficiency in Heart Failure Patients with Cardiac Amyloidosis: Pathophysiological Implications and Role in Differential Diagnosis.

Authors:  Giuseppe Palmiero; Marta Rubino; Emanuele Monda; Martina Caiazza; Lucia D'Urso; Guido Carlomagno; Federica Verrillo; Raffaele Ascione; Fiore Manganelli; Giuseppe Cerciello; Maria Luisa De Rimini; Eduardo Bossone; Giuseppe Pacileo; Paolo Calabrò; Paolo Golino; Luigi Ascione; Pio Caso; Giuseppe Limongelli
Journal:  J Cardiovasc Echogr       Date:  2021-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.